Abstract
Prior to the introduction of cyclosporin in the early 1980’s, it was widely held that steroids were a necessary part of immunosuppression for successful renal transplantation. The concept of using a “low dose” prednisolone approach, reported by McGeown in 1977 (1) was slow to be accepted until controlled trial evidence was forthcoming (2). Attempts to withdraw prednisolone from long term maintenance regimes even in stable, carefully selected patients (on azathioprine) were accompanied by frequent irreversible rejection episodes (3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McGowan MG, Kennedy JA Loughridge WGG, Douglas J, Alexander JA, Clarke SD, McEvoy J Hewitt JC: One hundred transplants in Belfast City Hospital. Lancet II: 648–651 1977.
D’Apice AJF, Becker GJ, Kincaid-Smith P, Mathew TH, Ng J, Hardie IR, Petrie JJB, Rigby RJ Dawborn J, Heale WF, Miarcn PJ: A prospective randomised trial of low dose versus high dose steroids in cadaveric renal transplantation. Transplantation 37: 373–377, 1984.
Lokkegaard H, Thaysen J.H.: Permanent withdrawal of prednisolone in necro-kidney transplantation Proc. EDTA 13: 216–222, 1976 (Publ. Pitman Medical).
Gray D, Shepherd H, Daar A: Oral versus intravenous high dose steroid treatment of renal allografi rejection, Lancet I: 117–118, 1978.
Russ GR, May S, Jacob CK et al: Experience with cyclosporine A and azathioprine double therapy in low risk recipients of first cadaveric renal allografts. Clin Transplantation, 4: 26–32, 1990.
Stabile C, Vincenti F, Garavoy M, Duca R, Melzer J, Feduskant Salvaterra O, Amend WT: Is a “low” dose of prednisolone better than a “high” dose at the time of renal transplantation? Braz J Med Biol Res, 19: 355–366 1986.
Fine RN: Transplantation in children. In: “Kidney Transplantation” (Ed PJ Morris), Academic Press, London, 1979, p 364.
Dumler F, Levin NW, Szego G, Bulpett AT, Prauss WE: Long term alternate day steroid therapy in renal transplantation. Transplantation, 34: 78–82, 1982.
Breitenfield FV, Hebert CA, Lemann J, Pirring WR, Kaufmann WM, Sampson D, Kalfleisch J and Beres JA: Stability of renal transplant function with alternate day corticosteroid therapy. J Am Med Assoc, 244: 157–159, 1980.
Mahony JF: Long term results and complications of transplantation: the kidney. Transplantation Proc, 21: 1433, 1989.
Raine AEG, Carter R, Mann J, Chapman JR, Morris PJ: Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression. Transplantation Proc, 19: 1820–1821, 1987.
Vathsala A, Weinberg RB, Schoenberg J, Grevel J, Dunn J, Goldstein RA, Van Buren CT, Lewis RM, Kahan BM: Lipid abnormalities in renal transplant recipients treated with cyclosporine. Transplantation Proc, 21: 3670–3673, 1989.
Bestifo AC, Petrie JJB, Rigby RJ, Hardie IR, Jacob CK, Russ GR, Mathew TH: A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low risk first cadaveric renal allograft recipients. Transplantation Proc, 21: 1604–1605, 1989.
Johnson RWG, Mallick NP, Bakran A, Pearson RC, Scott PD, Dyer P, Donaghue D, Morris D, Gokal R: Cadaver renal transplantation without maintenance steroids. Transplantation Proc, 21: 1581–1588, 1989.
Calne RY, White DJ, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Pentlow BN, Rolles K: Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet, II: 1323–1327, 1978.
European Multicentre Trial Group: Cyclosporine in cadaveric renal transplantations. One year following of a multicenter trial. Lancet, II: 986–989, 1983.
Nott D, Griffin PJ, Salaman JR: Low dose steroids do not augment cyclosporine but do diminish cyclosporine nephrotoxicity. Transplantation Proc, 17: 1289–1290, 1985.
Hall BM, Tiller DJ, Hardie J, Mahony J, Mathew TH, Thatcher G, Miach P, Thomson N, Shiel AG: Comparison of three immunosuppressive regimes in cadaver renal transplantation, N Engl J Med, 318: 1499–1507, 1988.
Simmons RL, Canafax DM, Strand M, Ascher NL, Payne WD, Sutherland DR, Najarian JS: Management and prevention of cyclosporine nephrotoxicity after renal transplantation: Use of low doses of cyclosporine, azathioprine and prednisolone. Transplantation Proc, 17: 266–275, 1985.
Posner MP, Mendez-Picon G, King A, Nelson KP, Spicer HG, Lee HM: Is sequential low dose immunotherapy the preferred treatment in cadaveric renal transplantation. Transplantation Proc, 21: 1594–1597, 1989.
Johnson RW, Mallick NP, Bakran A, Pearson RC, Scott PD, Dyer P, Donaghue D, Morris D, Gokal R: Cadaver renal transplantation without maintenance Steroids. Transplantation Proc, 21: 1581–1582, 1989.
Margreiter R, Bosmuller C, Speilberger M, Schmid TH, Konigsrainer A: Cyclosporine monotherapy after cadaveric renal transplantation. Transplantation Proc, 21: 1591–1593, 1989.
Griffin PJA, Salaman JR: Long term results of cyclosporine monotherapy in kidney transplantation. Transplantation Proc, 23: 992–993, 1991.
Klare B, Strom TM, Hahn H, Englesberger I, Muesel E, Illner XW, Adendroth D, Land W: Remarkable long term prognosis and excellent growth in kidney transplant children under cyclosporine monotherapy. Transplantation Proc, 23: 1013–1017, 1991.
MacDonald AS, Daloze P, Dandavino R, Jundal S, Bear L, Dossetor JB, Klassen J, Stiller CR, Lockwood B, Reeve C and the Canadian Transplant Group: A randomised study of cyclosporine with and without prednisolone in renal allograft recipients. Transplantation Proc, 19: 1865–1866, 1987.
Andrew J, Campistol AJ, Oppenheimer F, Ricart MJ, Vilardele J, Talbot R, Carretero P: Improved results in elderly renal transplants without prophylatic steroids. Clin Transplantation, 5: 3–6, 1991.
Squifflet JS, Sutherland DER, Rynasiewcz JJ, Field J, Heil J, Najarían JS: Combined immunosuppressive therapy with cyclosporin A and azathioprine. Transplantation, 41: 541–544, 1986.
Russ GR, May S, Jacob CK, Mathew TH, Pugsley DJ, Disney AP, Barratt LJ, Fraenkel MB, Clarkson AR, Woodroffe A: Experience with cyclosporine A and azathioprine double therapy in low risk recipients of first cadaveric renal allografts. Clin Transplantation, 4: 26–31, 1990.
Bry W, Warvarin V, Bohannon L, Feduska N, Straube B, Collins G, Levin B: Cadaveric renal transplant without prophylactic prednisolone therapy. Transplantation Proc, 23: 994–996, 1991.
Naik RB, Abdeen H, English J, Chakraborty J, Slapak M, Lee HA: Prednisolone withdrawal after 2 years in renal transplant patients receiving only this form of immunosuppression. Transplantation Proc, 11: 39–44, 1979.
Tamm M, Thiel G, Huser R, Brunner F, Hatsch M, Landmann J: Cyclosporine monotherapy after kidney transplantation since 1983. Transplantation Proc, 23: 997–998, 1991.
O’Connell PJ, D’Apice AJ, Walker RG, Francis DM, Clubie GJ, Kincaid-Smith P: Results of steroid withdrawal in renal allograft recipients in low dose cyclosporine A, azathioprine and prednisolone. Clin Transplantation, 2: 102–106, 1988.
Hariharan S, First MR, Munda R, Penn I, Schroeder TJ, Fidler J, Weiskittel P, Alexander JW: Prednisolone withdrawal in HLA identical living related donor transplant recipients. Transplantation Proc, 21: 1617–1619, 1989.
Frei D, Keusch G, Hugentobler M, Probst W, Uhlschmid G, Largiader F, Binswanger V: Withdrawal of steroids after cadaveric kidney allotransplantation on maintenance triple therapy. Transplantation Proc. 21:1620–1622, 1989.
Kupin et al: Steroid withdrawal in cyclosporine treated living related donor rental transplant recipients. Transplantation Proc, 21: 1623–1624, 1989.
Cristinelli L, Brunori G, Setti G, Manganoni A, Manganoni AM, Scolari F, Sandrini S, Scaini PS, Savoloi S, Camerini C, Maiorca R: Withdrawal of methylprednisolone on the sixth month in renal transplant recipients treated with cyclosporine. Transplantation Proc, 19: 2021–2023, 1987.
Osakabe T, Uchida H, Masaki Y, Yokota K, Sato K, Nakayama Y, Ohkubo M, Rumano K, Endo T, Watanabe K, Aso K: Studies on immunosuppression with low dose cyclosporine combined with mizoribine in experimental on clinical cadaveric renal allotransplantation. Transplantation Proc, 21: 1598–1600, 1989.
Platz KP, Eckhoff DE, Hullett DA, Gollinger HW: Prolongation of dog renal allograft survival by RS 61443 a new patient immunosuppressive agent. Transplantation Proc, 23: 497–498, 1991.
Kimball PM, Kerman RH, Kahan BO: Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression. Transplantation Proc, 23: 1027–1028, 1991.
Sheil AGR, Disney AP, Mathew TH, Amiss N, Excell L: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine or cyclosporin or both. Transplantation Proc, 23: 111–112, 1991.
Kahana L, Narvate J, Ackerman J, Lefor W, Weinstein S, Wright C, de Quiesada A, Baxter J, Shires D: OKT3 prophylaxis versus conventional drug therapy. Single centre perspective of multicentre trial. Amer J Kidney Disease, 14: 5–9, 1989.
Morris PJ: Single or multiple therapy. Transplantation Proc, 21: 820–822, 1989.
Land W: Kidney transplantation — state of the art. Transplantation Proc, 21: 1425–1429, 1989.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag London Limited
About this chapter
Cite this chapter
Mathew, T.H. (1991). Ideal Immunosuppression After Renal Transplantation: Are Steroids Needed?. In: Andreucci, V.E., Fine, L.G. (eds) International Yearbook of Nephrology 1992. Springer, London. https://doi.org/10.1007/978-1-4471-1892-3_14
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1892-3_14
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1894-7
Online ISBN: 978-1-4471-1892-3
eBook Packages: Springer Book Archive